ArticleJournal of cheminformatics2024
Deepmol: an automated machine and deep learning framework for computational chemistry.
Article in Journal of cheminformatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Random Forest Modeling to Predict Small Molecule Accumulation in Gram-Negative Bacteria.ACS infectious diseases · 2026Article
- GNN-MA: Soft Molecular Alignment with Cross-Graph Attention for Ligand-Based Virtual Screening.Molecules (Basel, Switzerland) · 2026Article
- Machine Learning in Homogeneous Catalysis: Basic Concepts and Best Practices.ACS catalysis · 2026Article
- Predicting precursors of plant specialized metabolites using DeepMol automated machine learning.Journal of integrative bioinformatics · 2025Article
- The Six Ds of Exponentials and drug discovery: A path toward reversing Eroom's law.Drug discovery today · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The domain of computational chemistry has experienced a significant evolution due to the introduction of Machine Learning (ML) technologies. Despite its potential to revolutionize the field, researchers are often encumbered by obstacles, such as the complexity of selecting optimal algorithms, the automation of data pre-processing steps, the necessity for adaptive feature engineering, and the assurance of model performance consistency across different datasets. Addressing these issues head-on, DeepMol stands out as an Automated ML (AutoML) tool by automating critical steps of the ML pipeline. DeepMol rapidly and automatically identifies the most effective data representation, pre-processing methods and model configurations for a specific molecular property/activity prediction problem. On 22 benchmark datasets, DeepMol obtained competitive pipelines compared with those requiring time-consuming feature engineering, model design and selection processes. As one of the first AutoML tools specifically developed for the computational chemistry domain, DeepMol stands out with its open-source code, in-depth tutorials, detailed documentation, and examples of real-world applications, all available at https://github.com/BioSystemsUM/DeepMol and https://deepmol.readthedocs.io/en/latest/ . By introducing AutoML as a groundbreaking feature in computational chemistry, DeepMol establishes itself as the pioneering state-of-the-art tool in the field.Scientific contributionDeepMol aims to provide an integrated framework of AutoML for computational chemistry. DeepMol provides a more robust alternative to other tools with its integrated pipeline serialization, enabling seamless deployment using the fit, transform, and predict paradigms. It uniquely supports both conventional and deep learning models for regression, classification and multi-task, offering unmatched flexibility compared to other AutoML tools. DeepMol's predefined configurations and customizable objective functions make it accessible to users at all skill levels while enabling efficient and reproducible workflows. Benchmarking on diverse datasets demonstrated its ability to deliver optimized pipelines and superior performance across various molecular machine-learning tasks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.